CRACKDOWN: China announced six-month crackdown on misconduct in its drug market, stepping up pressure on the problem-prone industry. Through December, investigators will examine manufacturers, markets, clinics and online stores.
WIDE SWEEP: The enforcement effort is aimed at stamping out unauthorized drug production, improper online drug retailing and sales of fake traditional Chinese medicines.
BRIBERY SCANDAL: The announcement came two days after Chinese police accused GlaxoSmithKline employees of conducting a multimillion-dollar bribery campaign to encourage doctors to prescribe its medications. Police said four employees including a vice president of GSK's China unit have been detained.